Patents by Inventor Henriette Emilie Sleijster-Selis

Henriette Emilie Sleijster-Selis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modification of Allergens for Immunotherapy
    Publication number: 20150273052
    Abstract: The present invention relates to pharmaceutical compositions for immunotherapy, for example for immunotherapy of peanut allergy. Further, the present invention relates to methods for the preparation of the present pharmaceutical compositions for immunotherapy, and their use in immunotherapy. Furthermore, the present invention relates to processes for modifying allergens thereby enhancing their application in immunotherapy. The invention also relates to the present modified allergens and pharmaceutical compositions comprising the present allergens, as well as to the use thereof in immunotherapy. According to a particularly preferred embodiment, the present invention relates to pharmaceutical compositions for immunotherapy comprising reduced and alkylated naturally occurring peanut allergens Ara h2 and/or Ara h6, or derivates or isoforms thereof wherein said pharmaceutical composition substantially does not comprise Ara h1 and/or Ara h3.
    Type: Application
    Filed: March 3, 2015
    Publication date: October 1, 2015
    Applicant: HAL ALLERGY HOLDING B.V.
    Inventors: Stefan Johan KOPPELMAN, Robertus Henricus Joannes Alfonsus VAN DEN HOUT, Henriette Emilie SLEIJSTER-SELIS, Dionisius Marinus Antonius Maria LUIJKX
  • MODIFICATION OF ALLERGENS FOR IMMUNOTHERAPY
    Publication number: 20110229523
    Abstract: The present invention relates to pharmaceutical compositions for immunotherapy, for example for immunotherapy of peanut allergy. Further, the present invention relates to methods for the preparation of the present pharmaceutical compositions for immunotherapy, and their use in immunotherapy. Furthermore, the present invention relates to processes for modifying allergens thereby enhancing their application in immunotherapy. The invention also relates to the present modified allergens and pharmaceutical compositions comprising the present allergens, as well as to the use thereof in immunotherapy. According to a particularly preferred embodiment, the present invention relates to pharmaceutical compositions for immunotherapy comprising reduced and alkylated naturally occurring peanut allergens Ara h2 and/or Ara h6, or derivates or isoforms thereof wherein said pharmaceutical composition substantially does not comprise Ara h1 and/or Ara h3.
    Type: Application
    Filed: July 6, 2009
    Publication date: September 22, 2011
    Applicant: HAL Allergy Holding B.V.
    Inventors: Stefan Johan Koppelman, Robertus Henricus Joannes Alfonsus Van Den Hout, Henriette Emilie Sleijster-Selis, Dionisius Marinus Antonious Maria Luijkx
  • MODIFICATION OF ALLERGENS
    Publication number: 20100086568
    Abstract: The invention relates to a process for modifying allergens to enhance their suitability in immunotherapy. The invention further relates to the modified allergens and pharmaceutical compositions thereof, as well as to their use in immunotherapy.
    Type: Application
    Filed: July 14, 2009
    Publication date: April 8, 2010
    Inventors: Stefan Johan KOPPELMAN, Robertus Henricus Joannes Alfonsus Van Den Hout, Henriëtte Emilie Sleijster-Selis, Dionisius Marinus Antonius Maria Luijkx